Literature DB >> 23417859

Colorectal cancer: a researcher's perspective of the molecular angel's gone eccentric in the Vale of Kashmir.

Aga Syed Sameer1.   

Abstract

Colorectal cancer (CRC), being the most common cancer, is the major cause of mortality and morbidity worldwide. In Kashmir, CRC has been found to be the third most common gastrointestinal cancer after esophageal and gastric. The etiology of CRC involves two pathways: chromosomal instability (CIN) and microsatellite instability. CIN occurs in 80-85 % of CRC resulting in either gross changes in chromosome structure and number or point mutations in the chromosomes. Many molecular studies have been carried out on CRC in Kashmir so as to elucidate the role of tumor suppressor genes and oncogenes in modulating the carcinogenesis. We searched the various literature databases including Medline, PubMed, ASCO abstracts, and ESMO abstracts for the papers regarding colorectal cancer published in English using the terms "Kashmir," "colorectal cancer," "colon cancer," "rectal cancer," "carcinogenesis," "epidemiology," "genetics," "mutation," and "polymorphism." Here in this review, I have shed light on the different studies carried on CRC in our Kashmiri population in an attempt to share what we know so far about the molecular carcinogenesis of CRC in Kashmir.

Entities:  

Mesh:

Year:  2013        PMID: 23417859     DOI: 10.1007/s13277-013-0692-4

Source DB:  PubMed          Journal:  Tumour Biol        ISSN: 1010-4283


  141 in total

1.  Solution structure of the single-strand break repair protein XRCC1 N-terminal domain.

Authors:  A Marintchev; M A Mullen; M W Maciejewski; B Pan; M R Gryk; G P Mullen
Journal:  Nat Struct Biol       Date:  1999-09

2.  Association of bladder cancer risk with an NAD(P)H:quinone oxidoreductase polymorphism in an ethnic Kashmiri population.

Authors:  Arshad A Pandith; Nighat P Khan; Zafar A Shah; Amin M Shah; Saleem M Wani; Mushtaq A Siddiqi
Journal:  Biochem Genet       Date:  2011-01-21       Impact factor: 1.890

Review 3.  Assessing TP53 status in human tumours to evaluate clinical outcome.

Authors:  T Soussi; C Béroud
Journal:  Nat Rev Cancer       Date:  2001-12       Impact factor: 60.716

4.  hOGG1 Ser326Cys polymorphism and lung cancer susceptibility.

Authors:  H Sugimura; T Kohno; K Wakai; K Nagura; K Genka; H Igarashi; B J Morris; S Baba; Y Ohno; C Gao; Z Li; J Wang; T Takezaki; K Tajima; T Varga; T Sawaguchi; J K Lum; J J Martinson; S Tsugane; T Iwamasa; K Shinmura; J Yokota
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  1999-08       Impact factor: 4.254

5.  Vegetable/fruit, smoking, glutathione S-transferase polymorphisms and risk for colorectal cancer in Taiwan.

Authors:  Chih-Ching Yeh; Ling-Ling Hsieh; Reiping Tang; Chung-Rong Chang-Chieh; Fung-Chang Sung
Journal:  World J Gastroenterol       Date:  2005-03-14       Impact factor: 5.742

6.  High prevalence of activated intraepithelial cytotoxic T lymphocytes and increased neoplastic cell apoptosis in colorectal carcinomas with microsatellite instability.

Authors:  R Dolcetti; A Viel; C Doglioni; A Russo; M Guidoboni; E Capozzi; N Vecchiato; E Macrì; M Fornasarig; M Boiocchi
Journal:  Am J Pathol       Date:  1999-06       Impact factor: 4.307

7.  Comprehensive analysis of SMAD4 mutations and protein expression in juvenile polyposis: evidence for a distinct genetic pathway and polyp morphology in SMAD4 mutation carriers.

Authors:  K L Woodford-Richens; A J Rowan; R Poulsom; S Bevan; R Salovaara; L A Aaltonen; R S Houlston; N A Wright; I P Tomlinson
Journal:  Am J Pathol       Date:  2001-10       Impact factor: 4.307

8.  Flat adenomas in the National Polyp Study: is there increased risk for high-grade dysplasia initially or during surveillance?

Authors:  Michael J O'brien; Sidney J Winawer; Ann G Zauber; Marijayne T Bushey; Stephen S Sternberg; Leonard S Gottlieb; John H Bond; Jerome D Waye; Melvin Schapiro
Journal:  Clin Gastroenterol Hepatol       Date:  2004-10       Impact factor: 11.382

Review 9.  Studying genetic variations in cancer prognosis (and risk): a primer for clinicians.

Authors:  Sevtap Savas; Geoffrey Liu
Journal:  Oncologist       Date:  2009-07-06

10.  Association of TP53 codon 72 polymorphism and the outcome of adjuvant therapy in breast cancer patients.

Authors:  Tatsuya Toyama; Zhenhuan Zhang; Mariko Nishio; Maho Hamaguchi; Naoto Kondo; Hirotaka Iwase; Hiroji Iwata; Satoru Takahashi; Hiroko Yamashita; Yoshitaka Fujii
Journal:  Breast Cancer Res       Date:  2007       Impact factor: 6.466

View more
  5 in total

1.  Lack of association between interleukin-4 -524C>T polymorphism and colorectal cancer susceptibility.

Authors:  Huanlei Wu; Jia Hu; Bo Liu; Yu Tao; Xiao Zhou; Xianglin Yuan
Journal:  Tumour Biol       Date:  2013-12-07

Review 2.  Genetic unraveling of colorectal cancer.

Authors:  Sabha Rasool; Vamiq Rasool; Tahira Naqvi; Bashir A Ganai; Bhahwal Ali Shah
Journal:  Tumour Biol       Date:  2014-02-27

3.  Quantitative assessment of the associations between DNA repair gene XRCC3 Thr241Met polymorphism and gastric cancer.

Authors:  Zhe Wang; Xu Chen; Bo Liu; Shide Li; Mingjun Liu; Hong Xue
Journal:  Tumour Biol       Date:  2013-10-03

4.  SMAD7 rs12953717 polymorphism contributes to increased risk of colorectal cancer.

Authors:  Yanliang Hu; Zhifang Sun; Anhua Zhang; Jinjie Zhang
Journal:  Tumour Biol       Date:  2013-08-16

5.  Tumor necrosis factor-α (TNF-α)-308G/A promoter polymorphism in colorectal cancer in ethnic Kashmiri population - A case control study in a detailed perspective.

Authors:  Mujeeb Zafar Banday; Henah Mehraj Balkhi; Zeenat Hamid; Aga Syed Sameer; Nissar A Chowdri; Ehtishamul Haq
Journal:  Meta Gene       Date:  2016-06-03
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.